Tirzepatide (10mg) is a dual GIP and GLP-1 receptor agonist studied for its impact on type 2 diabetes and obesity. Research highlights its role in improving insulin sensitivity, regulating appetite, supporting weight loss, and offering potential cardiovascular benefits.
Tirzepatide is a dual-receptor synthetic peptide used in laboratory research involving GLP-1 and GIP receptor pathways. This compound is supplied in lyophilized powder form and is intended strictly for in vitro applications conducted by qualified professionals in controlled environments.
Research Applications
Evaluation of GLP-1 and GIP receptor binding in lab-based models
Investigation of dual agonist signaling activity
Peptide interaction analysis in metabolic research environments
Product Details
Peptide: Tirzepatide
Concentrations Available: 10mg per vial, 15mg per vial, 30mg per vial, 45mg per vial, 60mg per vial and 90mg per vial
